Next Generation in Protein Characterization
RedShiftBio’s AQS3pro Wins a ‘The Analytical Scientist Innovation Award’ (TASIA) 2018
TASIA showcases the technologies driving the advancement of measurement science.
The Next Generation in Protein Characterization
The AQS3pro launches a new era in IR spectroscopy and protein characterization, bringing repeatable, high sensitivity, automated measurements to every stage of the biopharmaceutical pipeline. Powered by Microfluidic Modulation Spectroscopy (MMS), the AQS3pro measures the secondary structure of proteins over nearly four decades of concentration, from 0.1 mg/ml to over 200 mg/ml. Driven by the industry-leading AQS3delta Analytical Software package, it streamlines and simplifies 5 key measurements:
Aggregation | Quantitation | Stability | Structure | Similarity
See change in your protein, in your workflow, and in your efficiency.
Biotherapeutics Analytical Summit, Mar 4-8 2019, Alexandria, VA
Pittcon 2019, Mar 17-21, Philadelphia
HOS 2019, Apr 8 - 10 2019, San Mateo, CA
PEGS 2019 Apr 8-12, Boston, MA
2019 Colorado Protein Stability Conference, July 29 - Aug 1, Colorado
PEGS Europe, Nov 18-22, Lisbon
RedShift™, RedShiftBio™, See Change™, and AQS3™ are trademarks of RedShift BioAnalytics, Inc.
Class 1 Laser Device Complies with 21 CFR Chapter 1, Subchapter J, Part 1040.10